Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes.
Alleles
Animals
Antigen Presentation
Base Sequence
CD4-Positive T-Lymphocytes
/ immunology
Cattle
Cells, Cultured
Computational Biology
/ methods
Computer Simulation
Epitopes, T-Lymphocyte
/ immunology
High-Throughput Nucleotide Sequencing
/ methods
Histocompatibility Antigens Class II
/ genetics
Ligands
Mass Spectrometry
/ methods
Peptides
/ immunology
Protein Binding
Theileria annulata
Theileria parva
Theileriasis
/ immunology
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
15 05 2021
15 05 2021
Historique:
received:
16
12
2020
accepted:
01
03
2021
pubmed:
2
4
2021
medline:
18
9
2021
entrez:
1
4
2021
Statut:
ppublish
Résumé
MHC peptide binding and presentation is the most selective event defining the landscape of T cell epitopes. Consequently, understanding the diversity of MHC alleles in a given population and the parameters that define the set of ligands that can be bound and presented by each of these alleles (the immunopeptidome) has an enormous impact on our capacity to predict and manipulate the potential of protein Ags to elicit functional T cell responses. Liquid chromatography-mass spectrometry analysis of MHC-eluted ligand data has proven to be a powerful technique for identifying such peptidomes, and methods integrating such data for prediction of Ag presentation have reached a high level of accuracy for both MHC class I and class II. In this study, we demonstrate how these techniques and prediction methods can be readily extended to the bovine leukocyte Ag class II DR locus (BoLA-DR). BoLA-DR binding motifs were characterized by eluted ligand data derived from bovine cell lines expressing a range of DRB3 alleles prevalent in Holstein-Friesian populations. The model generated (NetBoLAIIpan, available as a Web server at www.cbs.dtu.dk/services/NetBoLAIIpan) was shown to have unprecedented predictive power to identify known BoLA-DR-restricted CD4 epitopes. In summary, the results demonstrate the power of an integrated approach combining advanced mass spectrometry peptidomics with immunoinformatics for characterization of the BoLA-DR Ag presentation system and provide a prediction tool that can be used to assist in rational evaluation and selection of bovine CD4 T cell epitopes.
Identifiants
pubmed: 33789985
pii: jimmunol.2001409
doi: 10.4049/jimmunol.2001409
pmc: PMC8113073
mid: NIHMS1683098
doi:
Substances chimiques
BoLA-DRB3 antigen
0
Epitopes, T-Lymphocyte
0
Histocompatibility Antigens Class II
0
Ligands
0
Peptides
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2489-2497Subventions
Organisme : NIAID NIH HHS
ID : HHSN272201200010C
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20002174
Pays : United Kingdom
Informations de copyright
Copyright © 2021 by The American Association of Immunologists, Inc.
Références
Immunogenetics. 1997;45(6):379-85
pubmed: 9089095
J Proteome Res. 2018 Jan 5;17(1):559-567
pubmed: 29115832
Nat Biotechnol. 2019 Nov;37(11):1283-1286
pubmed: 31611696
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Mol Cell Proteomics. 2019 Dec;18(12):2459-2477
pubmed: 31578220
Vet Parasitol. 2016 Aug 30;227:130-7
pubmed: 27523949
NPJ Vaccines. 2020 Jan 3;5:2
pubmed: 31908851
Anim Genet. 1991;22(4):343-52
pubmed: 1952283
Nucleic Acids Res. 2017 Jul 3;45(W1):W458-W463
pubmed: 28407089
BMC Genet. 2018 May 22;19(1):33
pubmed: 29788904
BMC Genomics. 2020 Apr 3;21(1):279
pubmed: 32245418
Meta Gene. 2014 Feb 19;2:176-90
pubmed: 25606401
Sci Rep. 2020 Jul 30;10(1):12857
pubmed: 32732984
J Dairy Sci. 2009 Jun;92(6):2965-70
pubmed: 19448029
PLoS Pathog. 2006 Apr;2(4):e27
pubmed: 16604154
J Proteome Res. 2020 Jun 5;19(6):2304-2315
pubmed: 32308001
Mol Cell Proteomics. 2018 Mar;17(3):533-548
pubmed: 29242379
Immunity. 2019 Oct 15;51(4):766-779.e17
pubmed: 31495665
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
Immunogenetics. 2001 Feb;53(1):74-81
pubmed: 11261936
Nat Protoc. 2019 Jun;14(6):1687-1707
pubmed: 31092913
J Immunol. 2016 Sep 15;197(6):2492-9
pubmed: 27511729
Front Immunol. 2020 Jun 23;11:1304
pubmed: 32655572
J Dairy Sci. 2012 Jan;95(1):420-31
pubmed: 22192221
Gene. 2013 Apr 25;519(1):150-8
pubmed: 23333729
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
J Dairy Sci. 2007 Apr;90(4):1943-6
pubmed: 17369234
Immunogenetics. 1988;27(2):110-20
pubmed: 2891610
Annu Rev Genomics Hum Genet. 2000;1:117-37
pubmed: 11701627
Vaccine. 2012 Oct 19;30(47):6678-85
pubmed: 22959980
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
Nature. 1992 Aug 27;358(6389):764-8
pubmed: 1380674
Anim Genet. 2008 Oct;39(5):561-3
pubmed: 18637877
Immunity. 2017 Feb 21;46(2):315-326
pubmed: 28228285
Proteins. 2001 Oct 1;45(1):47-54
pubmed: 11536359
Nat Biotechnol. 2018 Dec 17;:
pubmed: 30556813
Rev Bras Parasitol Vet. 2014 Apr-Jun;23(2):150-6
pubmed: 25054492
Nat Biotechnol. 2020 Feb;38(2):199-209
pubmed: 31844290
BMC Biotechnol. 2008 Feb 14;8:14
pubmed: 18275601
Front Immunol. 2018 Aug 06;9:1795
pubmed: 30127785
Nat Rev Immunol. 2006 Apr;6(4):271-82
pubmed: 16557259
J Vet Med Sci. 2006 Dec;68(12):1289-95
pubmed: 17213697
Front Immunol. 2018 Apr 27;9:912
pubmed: 29780384
Immunogenetics. 2019 Jul;71(7):445-454
pubmed: 31183519
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Genome Med. 2018 Nov 16;10(1):84
pubmed: 30446001
Vet Immunol Immunopathol. 1993 Jan;35(3-4):253-73
pubmed: 8430496
ISRN Vet Sci. 2012 May 28;2012:872710
pubmed: 23738132
Tissue Antigens. 2003 Jul;62(1):55-65
pubmed: 12859595
Tissue Antigens. 2015 Dec;86(6):419-30
pubmed: 26514650